Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028
According
to Triton, the surgical site infection control market in Latin America is
expected to propel with a CAGR of 6.54% in the forecast period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries reviewed in this market include:
• Brazil
• Mexico
• Rest of Latin America
The
rate of incidence of healthcare-associated infections (HAIs) in Mexican
hospitals ranges from around 2.1 to 15.8%. Nayarit’s CMQ hospital estimates
that, the average incidence rate of surgical site infections in the hospitals
in Mexico is 9.5%. Several preventative measures, such as administrating
antibiotics (prophylaxis) an hour before surgery, cleaning the surgical area using
a chlorhexidine-based surgical antibacterial soap, and using sterile techniques
to handle surgical instruments are being taken into account in order to prevent
these infections from occurring.
Further,
obesity, diabetes mellitus, and the presence of surgical drains are some of the
risk factors associated with SSIs, stated the National Cancer Institute.
Therefore, the growing prevalence of SSIs is creating a huge demand for
controlling the spread of these infections in Mexico. This demand has led to
the adoption of several preventive measures, which is helping the Mexican
surgical site infection control market to grow.
Surgical
site infections are the type of infections that develop in an organ after
surgery due to an incision made in the body during this process. These are the
most commonly occurring and the costliest of all HAIs. SSIs constitute 20% of
the total healthcare-associated infections in Brazil. Thus, in its efforts to control
the spread of HAIs, the country’s health ministry implemented institutional
surveillance in 1992, which made it mandatory for public and private hospitals
to set up an HAI-control committee. Such efforts are expected to advance the
Brazilian SSI control market in the years to come.
Belimed
AG is among the top globally renowned companies supplying cleaning,
disinfecting, and sterilizing products for use in the medical and life sciences
industries. It has a huge customer base, which includes multinational
pharmaceutical companies, hospitals, as well as large medical practices.
Founded in 1990, the company has a workforce of more than 1200 employees.
Belimed has a strong network of authorized partners, who help the company
strengthen its foothold in over 80 countries across the world.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.
MARKET DEFINITION
2.2.
PORTER’S FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3.
IMPACT OF COVID-19 ON SURGICAL
SITE INFECTION CONTROL MARKET
2.4.
MARKET ATTRACTIVENESS INDEX
2.5.
VENDOR SCORECARD
2.6.
KEY INSIGHTS
2.7.
MARKET DRIVERS
2.7.1. ENACTMENT
OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES
2.7.2. GROWING
AGING POPULATION
2.8.
MARKET RESTRAINTS
2.8.1. LACK
OF INFECTION CONTROL PROGRAMS
2.8.2. SURGING
USE OF OUTPATIENT PROCEDURES
2.8.3. INCREASED
USAGES OF MEDICAL DISPOSABLE ITEMS
2.9.
MARKET OPPORTUNITIES
2.9.1. RISING
INCIDENCE OF SURGICAL PROCEDURES
2.9.2. SIGNIFICANT
RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1.
SUPERFICIAL INCISIONAL SSI
4.2.
DEEP INCISIONAL SSI
4.3.
ORGAN OR SPACE SSI
5. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1.
HOSPITALS
5.2.
AMBULATORY SURGICAL CENTERS
6. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. SURGICAL
SITE INFECTION CONTROL MARKET - LATIN AMERICA
7.1.
COUNTRY ANALYSIS
7.1.1. MEXICO
7.1.2. BRAZIL
7.1.3. REST
OF LATIN AMERICA
8. COMPANY
PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9. RESEARCH
METHODOLOGY & SCOPE
9.1.
RESEARCH SCOPE &
DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2.
SOURCES OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3.
RESEARCH METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
TABLE
2 VENDOR SCORECARD
TABLE
3 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE
4 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE
5 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE
6 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
7 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
2 TYPES OF HEALTHCARE-ASSOCIATED
INFECTIONS
FIGURE
3 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE
4 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
5 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
6 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $
MILLION)
FIGURE
7 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE
8 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028
(IN $ MILLION)
FIGURE
9 LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
10 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
11 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE
12 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE
13 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE
14 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
15 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
16 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE
17 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
18 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE
19 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE
20 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
21 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE
22 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE
23 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
24 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE
25 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE
26 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE
27 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE
28 LATIN AMERICA SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE
29 MEXICO SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
30 BRAZIL SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
31 REST OF LATIN AMERICA SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)